Andrew D. Howard

9.0k total citations · 1 hit paper
53 papers, 5.0k citations indexed

About

Andrew D. Howard is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Andrew D. Howard has authored 53 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 16 papers in Surgery and 15 papers in Molecular Biology. Recurrent topics in Andrew D. Howard's work include Regulation of Appetite and Obesity (15 papers), Receptor Mechanisms and Signaling (11 papers) and Biochemical Analysis and Sensing Techniques (11 papers). Andrew D. Howard is often cited by papers focused on Regulation of Appetite and Obesity (15 papers), Receptor Mechanisms and Signaling (11 papers) and Biochemical Analysis and Sensing Techniques (11 papers). Andrew D. Howard collaborates with scholars based in United States, Denmark and United Kingdom. Andrew D. Howard's co-authors include Scott D. Feighner, Lex H.T. Van der Ploeg, Carina P. Tan, Roy G. Smith, Donna L. Hreniuk, Karen K. McKee, Oksana Palyha, Maria A. Bednarek, Ravi P. Nargund and Susan R. George and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Endocrine Reviews.

In The Last Decade

Andrew D. Howard

53 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Kidney Transplantation as Primary Therapy for End-Stage Renal Disease

2008 430 citations Andrew D. Howard et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew D. Howard United States	29	2.3k	1.5k	1.4k	1.3k	1.2k	53	5.0k
Kenji Shima Japan	37	1.6k 0.7×	866 0.6×	916 0.7×	1.9k 1.4×	1.5k 1.2×	159	5.1k
R. S. Sherwin United States	36	659 0.3×	317 0.2×	1.2k 0.9×	2.6k 1.9×	1.5k 1.2×	84	4.9k
Pierre Carayon France	34	314 0.1×	150 0.1×	1.3k 0.9×	1.6k 1.2×	554 0.5×	98	5.0k
Ole Schmitz Denmark	41	371 0.2×	398 0.3×	1.7k 1.3×	2.3k 1.7×	1.4k 1.2×	136	5.2k
Renato Lauro Italy	52	339 0.1×	333 0.2×	2.8k 2.0×	1.7k 1.2×	1.5k 1.3×	106	6.9k
Jean‐Marc Lacorte France	29	1.6k 0.7×	1.0k 0.7×	1.0k 0.7×	720 0.5×	1.4k 1.2×	69	4.7k
Johan Hoffstedt Sweden	42	835 0.4×	420 0.3×	1.7k 1.2×	840 0.6×	3.9k 3.3×	78	6.8k
David P. Brooks United States	36	374 0.2×	195 0.1×	1.4k 1.0×	579 0.4×	819 0.7×	178	4.0k
Signe S. Torekov Denmark	30	498 0.2×	302 0.2×	1.1k 0.8×	1.7k 1.2×	1.3k 1.1×	87	3.9k
Frederick A.O. Mendelsohn Australia	41	507 0.2×	163 0.1×	2.0k 1.5×	1.4k 1.0×	610 0.5×	106	4.9k

Countries citing papers authored by Andrew D. Howard

Since Specialization

Citations

This map shows the geographic impact of Andrew D. Howard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. Howard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. Howard more than expected).

Fields of papers citing papers by Andrew D. Howard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew D. Howard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. Howard. The network helps show where Andrew D. Howard may publish in the future.

Co-authorship network of co-authors of Andrew D. Howard

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew D. Howard. A scholar is included among the top collaborators of Andrew D. Howard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew D. Howard. Andrew D. Howard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sam, Ramin, Laura I. Rankin, Ifeoma Ulasi, et al.. (2023). Vaccination for Patients Receiving Dialysis. Kidney Medicine. 6(3). 100775–100775. 14 indexed citations

Rudenko, Olga, Jin Shang, Jeppe H. Ekberg, et al.. (2018). The aromatic amino acid sensor GPR142 controls metabolism through balanced regulation of pancreatic and gut hormones. Molecular Metabolism. 19. 49–64. 47 indexed citations

Wingard, Rebecca L., Andrew D. Howard, Nancy Armistead, et al.. (2017). Right TraC™ Post-Hospitalization Care Transitions Program to Reduce Readmissions for Hemodialysis Patients. American Journal of Nephrology. 45(6). 532–539. 11 indexed citations

Ekberg, Jeppe H., M. Hauge, Andreas Nygaard Madsen, et al.. (2016). GPR119, a Major Enteroendocrine Sensor of Dietary Triglyceride Metabolites Coacting in Synergy With FFA1 (GPR40). Endocrinology. 157(12). 4561–4569. 88 indexed citations

Lai, Zhong, Shuwen He, Edward C. Sherer, et al.. (2015). Discovery of substituted (4-phenyl-1H-imidazol-2-yl)methanamine as potent somatostatin receptor 3 agonists. Bioorganic & Medicinal Chemistry Letters. 25(17). 3520–3525. 2 indexed citations

Walsh, Shawn P., Changyou Zhou, Jiafang He, et al.. (2011). 3-Substituted 3-(4-aryloxyaryl)-propanoic acids as GPR40 agonists. Bioorganic & Medicinal Chemistry Letters. 21(11). 3390–3394. 20 indexed citations

Szewczyk, Jason W., John J. Acton, Alan D. Adams, et al.. (2010). Design of potent and selective GPR119 agonists for type II diabetes. Bioorganic & Medicinal Chemistry Letters. 21(9). 2665–2669. 21 indexed citations

Sano, Hideki, Scott D. Feighner, Donna L. Hreniuk, et al.. (2004). Characterization of the bombesin-like peptide receptor family in primates. Genomics. 84(1). 139–146. 64 indexed citations

Shearman, Lauren P., Ramon E. Camacho, D. Sloan Stribling, et al.. (2003). Chronic MCH-1 receptor modulation alters appetite, body weight and adiposity in rats. European Journal of Pharmacology. 475(1-3). 37–47. 141 indexed citations

10.

Martin, William J., Erin McGowan, Doreen E. Cashen, et al.. (2002). Activation of melanocortin MC4 receptors increases erectile activity in rats ex copula. European Journal of Pharmacology. 454(1). 71–79. 64 indexed citations

11.

Bednarek, Maria A., Carina P. Tan, Donna L. Hreniuk, et al.. (2002). Synthesis and Biological Evaluation in Vitro of a Selective, High Potency Peptide Agonist of Human Melanin-concentrating Hormone Action at Human Melanin-concentrating Hormone Receptor 1. Journal of Biological Chemistry. 277(16). 13821–13826. 25 indexed citations

12.

MacNeil, Douglas J., Andrew D. Howard, Xiao-Ming Guan, et al.. (2002). The role of melanocortins in body weight regulation: opportunities for the treatment of obesity. European Journal of Pharmacology. 440(2-3). 141–157. 54 indexed citations

13.

Howard, Andrew D.. (2001). Long-term management of the renal transplant recipient: Optimizing the relationship between the transplant center and the community nephrologist. American Journal of Kidney Diseases. 38(6). S51–S57. 13 indexed citations

14.

Ye, Zhixiong, Raman K. Bakshi, Meng‐Hsin Chen, et al.. (2000). Modeling directed design and biological evaluation of quinazolinones as non-peptidic growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 10(1). 5–8. 19 indexed citations

15.

Tan, Carina P., Karen K. McKee, David H. Weinberg, et al.. (1999). Molecular analysis of a new splice variant of the human melanocortin‐1 receptor. FEBS Letters. 451(2). 137–141. 44 indexed citations

16.

Lee, Dennis K, Tuan Nguyen, Gary P. O’Neill, et al.. (1999). Discovery of a receptor related to the galanin receptors. FEBS Letters. 446(1). 103–107. 400 indexed citations

17.

McKee, Karen K., Oksana Palyha, Scott D. Feighner, et al.. (1997). Molecular Analysis of Rat Pituitary and Hypothalamic Growth Hormone Secretagogue Receptors. Molecular Endocrinology. 11(4). 415–423. 289 indexed citations

18.

Bennett, Pamela A., Gregory B. Thomas, Andrew D. Howard, et al.. (1997). Hypothalamic Growth Hormone Secretagogue-Receptor (GHS-R) Expression Is Regulated by Growth Hormone in the Rat. Endocrinology. 138(11). 4552–4557. 160 indexed citations

19.

McKee, Karen K., Carina P. Tan, Oksana Palyha, et al.. (1997). Cloning and Characterization of Two Human G Protein-Coupled Receptor Genes (GPR38 and GPR39) Related to the Growth Hormone Secretagogue and Neurotensin Receptors. Genomics. 46(3). 426–434. 246 indexed citations

20.

Howard, Andrew D., et al.. (1990). Routine Serologic Tests in the Differential Diagnosis of the Adult Nephrotic Syndrome. American Journal of Kidney Diseases. 15(1). 24–30. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact